CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Paid in Capital	(Accumulated Deficit) Retained Earnings
Beginning Balance at Dec. 31, 2018	$ 37,205,876	$ 76,926	$ 33,961,903	$ 3,167,047
Beginning Balance, shares at Dec. 31, 2018		7,692,624
Restricted stock grants issued		$ 414	(414)
Restricted stock grants issued, Shares		41,343
Restricted stock grant forfeitures		$ (50)	50
Restricted stock grant forfeitures, Shares		(4,961)
Issuance of common stock under rights offering, net of expenses	6,280,987	$ 16,013	6,264,974
Issuance of common stock under rights offering, net of expenses, Shares		1,601,291
Stock-based compensation	102,989		102,989
Net income	590,619			590,619
Dividends	(2,114,555)			(2,114,555)
Ending Balance at Dec. 31, 2019	$ 42,065,916	$ 93,303	40,329,502	1,643,111
Ending Balance, shares at Dec. 31, 2019	9,330,297	9,330,297
Restricted stock grants issued		$ 128	(128)
Restricted stock grants issued, Shares		12,821
Stock-based compensation	$ 126,035		126,035
Net income	274,341			274,341
Dividends	(2,427,401)			(2,427,401)
Ending Balance at Dec. 31, 2020	$ 40,038,891	$ 93,431	$ 40,455,409	$ (509,949)
Ending Balance, shares at Dec. 31, 2020	9,343,118	9,343,118